Find Medicine

IRESSA 250

إيريسا 250 | Chemotherapeutics and Drugs Affecting Immunoresponse
IRESSA 250

Drug Category

Immune system

Medicinal form

Tablets

Active ingredient

Gefitinib

Concentration

250mg

Manufacturer

AstraZeneca

Price

10600 EGP

Uses

is a first line treatment for patients with EGFR mutation for 1 locally advanced or metastatic,
Uses: effective in esophageal cancer patients whose tumours harboured additional copies of the EGFR gene. there is potential for its use in the treatment of other cancers where EGFR overexpression is involved. Erlotinib is another EGFR tyrosine kinase inhibitor that has a similar mechanism of action to gefitinib.

Note: The information provided about this drug does not substitute for consulting a doctor.

IRESSA 250

The doctor answers your questions quickly

Are you experiencing any symptoms at the moment? Now many specialist doctors are ready to help you.

Calculators

Calculator for Health is a very useful tool to help individuals better understand and manage their health. By providing measurable data, users can make better informed decisions to maintain or improve their well-being.

See list pharmacies

Direct Access to Pharmacy Through Innovative Portal

Empower your health journey with Direct Access to Pharmacy Through Innovative Portal - Your gateway to seamless and efficient healthcare solutions at your fingertips

See list pharmacies